Back
ACADIA Pharmaceuticals Vs. Geovax Labs Industry Stock Comparison
Sell
41
ACAD
ACADIA Pharmaceuticals
Last Price:
14.82
Seasonality Move:
14.68%
Sell
18
GOVX
Geovax Labs
Last Price:
1.93
Seasonality Move:
-5.24%
Sell
41
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.81. The Score for ACAD is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Geovax Labs (GOVX)
is a Sell
Is Geovax Labs a Buy, Sell or Hold?
- The current Geovax Labs [GOVX] share price is $1.92. The Score for GOVX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- GOVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.
GOVX Stock Price Chart
What is Geovax Labs's stock price today?
-
The Geovax Labs share price today is $1.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOVX is experiencing selling pressure, which indicates risk of future bearish movement.
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 810886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.49 - 15.17) | Sell |
| Bollinger Bands (100): | (14.77 - 17.37) | Sell |
GOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 38.07 | Sell |
| Chaikin Money Flow: | -190181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.98 - 2.24) | Sell |
| Bollinger Bands (100): | (1.53 - 4.27) | Sell |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.59 | Buy |
| 20-day SMA: | 14.73 | Buy |
| 50-day SMA: | 15.45 | Sell |
| 200-day SMA: | 18.05 | Sell |
| 8-day EMA: | 14.69 | Buy |
| 20-day EMA: | 14.84 | Sell |
| 50-day EMA: | 15.35 | Sell |
| 200-day EMA: | 17.73 | Sell |
GOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.05 | Sell |
| 20-day SMA: | 2.07 | Sell |
| 50-day SMA: | 2.99 | Sell |
| 200-day SMA: | 2.53 | Sell |
| 8-day EMA: | 2.02 | Sell |
| 20-day EMA: | 2.16 | Sell |
| 50-day EMA: | 2.55 | Sell |
| 200-day EMA: | 10.39 | Sell |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.29 per share.
Geovax Labs Earnings Growth & GOVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ACADIA Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Geovax Labs Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||